Dana Hambly - National Health Director Relations

WX6 Stock  EUR 71.50  1.00  1.38%   

Insider

Dana Hambly is Director Relations of National Health Investors
Phone615-890-9100
Webhttps://www.nhireit.com

National Health Management Efficiency

The company has return on total asset (ROA) of 0.0336 % which means that it generated a profit of $0.0336 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0467 %, meaning that it generated $0.0467 on every $100 dollars invested by stockholders. National Health's management efficiency ratios could be used to measure how well National Health manages its routine affairs as well as how well it operates its assets and liabilities.
National Health Investors has accumulated 1.15 B in total debt with debt to equity ratio (D/E) of 91.0, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. National Health Investors has a current ratio of 2.17, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist National Health until it has trouble settling it off, either with new capital or with free cash flow. So, National Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like National Health Investors sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for National to invest in growth at high rates of return. When we think about National Health's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Matt MBAQBE Insurance Group
N/A
Mario GrecoZurich Insurance Group
64
MAICD FCPAQBE Insurance Group
N/A
Jeffrey DaileyZurich Insurance Group
66
Christopher WhitfordSafety Insurance Group
40
George CPCUSafety Insurance Group
56
BA ACAQBE Insurance Group
N/A
Glenn HiltpoldSafety Insurance Group
52
Sierra SignorelliZurich Insurance Group
48
George QuinnZurich Insurance Group
57
Alison MartinZurich Insurance Group
49
Jason BScQBE Insurance Group
56
Ashley DalziellQBE Insurance Group
N/A
Tulsi NaiduZurich Insurance Group
50
Samuel BAQBE Insurance Group
53
James CPCUSafety Insurance Group
63
Kristof TerrynZurich Insurance Group
56
John DragoSafety Insurance Group
56
Peter GigerZurich Insurance Group
59
Inder BComQBE Insurance Group
N/A
MBA BSZurich Insurance Group
53
is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHIs portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals. NATL HEALTH operates under REIT - Healthcare Facilities classification in Germany and is traded on Frankfurt Stock Exchange. It employs 16 people. National Health Investors (WX6) is traded on Frankfurt Exchange in Germany and employs 25 people.

Management Performance

National Health Investors Leadership Team

Elected by the shareholders, the National Health's board of directors comprises two types of representatives: National Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of National. The board's role is to monitor National Health's management team and ensure that shareholders' interests are well served. National Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, National Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
Dana Hambly, Director Relations
David Travis, VP Officer
Kimberly Ouimet, Director HR
John Spaid, Exec CFO
Colleen Schaller, Real Mang
Eric Mendelsohn, CEO Pres
Michelle Kelly, VP Investments
Kristin Gaines, Chief Officer
Kevin Pascoe, Chief Officer
Susan Sidwell, Co Sec

National Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is National Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Additional Information and Resources on Investing in National Stock

When determining whether National Health Investors offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of National Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of National Health Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on National Health Investors Stock:
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in National Health Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Please note, there is a significant difference between National Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if National Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.